Nkarta, Inc.
NKTX$152M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaSOUTH SAN FRANCISCO
Drugs in Pipeline
2
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
NKTX News
Catalyst Timeline
0 upcoming, 1 past
No catalysts found.
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Fludarabine, Cyclophosphamide | Phase 2 | Lupus Nephritis | - | - |
NKX019 | Phase 2 | Systemic Sclerosis | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply